BSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.
Cohance Lifesciences Ltd: key numbers
- Share price
- ₹433.00
- Market cap
- ₹16,566 Cr
- Revenue (annual)
- ₹2,269 Cr
- Net profit (annual)
- ₹179.2 Cr
- P/E (TTM)
- 155.9×Sector 42.0×
- Promoter holding
- 57.48%-0.01% QoQ
- FII holding
- 7.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cohance Lifesciences Ltd
All →Cohance Lifesciences Earnings Call Transcript: Key Takeaways
Q2 revenue rose about 13% QoQ to ₹477 Cr and adjusted EBITDA reached about ₹46 Cr (~10% margin), but both remain below last year. H2 YoY growth is promised without figures, and FY27 specialty chemicals guidance was cut to decline.
Cohance Lifesciences Results Update
Cohance Lifesciences issued a press release on its unaudited Q2 and H1 FY27 results. It reported lower year-on-year revenue and an expected stronger second half.
Cohance Lifesciences Investor Presentation: Key Takeaways
Q2FY27 revenue INR 4,766 Mn, down 14.2% YoY but up 12.9% QoQ. Adjusted EBITDA margin 9.6%, adjusted PAT INR 74 Mn back positive. Strategy centres on One Cohance integration and H2 recovery.
Cohance Lifesciences Q2 FY27 Results: Net Profit ₹2.3 Cr, Down 96.5% YoY
Cohance Lifesciences Ltd reported revenue from operations of ₹476.6 Cr (-14.2% YoY) and net profit of ₹2.3 Cr (-96.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2.3 Cr · -96.5% YoY
Cohance Lifesciences Adverse Business Impact
Cohance Lifesciences disclosed a TGPCB closure order halting manufacturing at its Suryapet site after an industrial accident. The financial impact cannot yet be quantified.
Cohance Lifesciences Board Meeting Date
Cohance Lifesciences will hold a board meeting on 6 November 2026 to approve Q2 and half-year results. The trading window stays closed until 9 November 2026.
Other management change announcements
All →Mayur Uniquoters Management Change
Mayur Uniquoters disclosed the resignations of two senior management personnel, Vikrant Mathur and Rakesh Kumar Saxena, effective close of business on 6 November 2026. The company accepted both resignations.
Panchatv Bharat Management Change
Panchatv Bharat's Company Secretary Chanchal Khandelwal resigned effective 31 October 2026. The filing cites a better career opportunity as the reason.
Uniphos Enterprises Management Change
Uniphos Enterprises appointed Girish Balkrishan Goenka as Chief Executive Officer, effective 6 November 2026, approved at a board meeting that day. The appointment is a senior management change with no money involved.
Sigma Advanced Systems Management Change
Sigma Advanced Systems appointed two non-executive directors and three directors resigned, including two independent directors. Sunil Kumar Kalidindi was redesignated as Whole Time Director and CEO.
Dhunseri Tea & Industries Management Change
Dhunseri Tea & Industries re-appointed Bharati Dhanuka as Executive Director (MD) for 36 months, effective 01-Apr-2027. The decision was taken at the 06-Nov-2026 board meeting.
- Execution
- 36 months from 01-04-2027
Lynx Machinery & Commercials Management Change
Lynx Machinery's internal auditor Ambavat Jain resigned with immediate effect, citing no material reason. I.G. Naik & Co. was appointed internal auditor for FY 2026-27.
- Execution
- April 1, 2026 to March 31, 2027